The Rhodium–rhenium complex 1 can be regarded as prototype of a new generation of hydrogenation catalysts. A salient-characteristic is the coupling of an Rh1 center—known to exhibit catalytic activity in hydrogenations—with a bis(diphenylphosphido) ligand, which contains a pseudo-tetrahedrally coordinated stereogenic Re atom in the skeletal framework. For example, α-acetamidoacrylic acid is hydrogenated in presence of 1 (0.4 mol-% in THF) with 1 atm H2 at room temperature to (R)-N-acetylalanine with 98% ee (yield: 82%).
No takes yet. Share an insight, caveat, or question.
Zwick et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: